SANDUPHQ Stock View

Sandu Pharmaceuticals Ltd
stock-view-header

icon -0.71 | -0.96
Market Cap ₹( Cr.)
715.88
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)

Stock View

Last Updated On.
01-Oct-2023
 

The average score for Sandu Pharmaceuticals Ltd stands at 5 against 6, three months back.

Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic proprietary medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company also offers products, such as an immunity kit and a power herbs range. The Company's products are sold through e-commerce marketplaces.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
60.74
100 DMA(₹)
58.38
200 DMA(₹)
59.66
52 Weeks Range
49.00     82.60

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required